Pathogen reduction technologies need to evaluate Fc-mediated antibody functions

Affiliations

¹ North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
² Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, Maryland, USA.

Comment

Daniele Focosi et al. Transfusion. 2022 Aug.

. 2022 Aug;62(8):1680-1681.

doi: 10.1111/trf.16995.

¹ North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
² Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, Maryland, USA.

No abstract available

Comment on

Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.
Bagri A, de Assis RR, Tsai CT, Simmons G, Mei ZW, Von Goetz M, Gatmaitan M, Stone M, Di Germanio C, Martinelli R, Darst O, Rioveros J, Robinson PV, Ward D, Ziman A, Seftel D, Khan S, Busch MP, Felgner PL, Corash LM. Bagri A, et al. Transfusion. 2022 Mar;62(3):570-583. doi: 10.1111/trf.16819. Epub 2022 Feb 12. Transfusion. 2022. PMID: 35128658 Free PMC article.